
    
      The purpose of this study is to investigate and evaluate the effects of liraglutide combined
      with short-term continuous subcutaneous insulin infusion(CSII)(1.CSII alone; 2.liraglutide
      combined with CSII) on long-term glycemic control and Î²-cell function in newly diagnosed type
      2 diabetic patients.
    
  